MoneyWorks4Me

Caplin Point gets EIR from USFDA for sterile injectable plant in Tamil Nadu

08 May 2017 Evaluate

Caplin Point Laboratories has received the Establishment Inspection Report (EIR) from USFDA for the inspection carried out during October 21 - 27, 2016 at its sterile injectable plant at Gummidipoondi, Tamil Nadu. The facility, capable of manufacturing Liquid Injectables in Vials, Ampoules, Lyophilized Vials and Ophthalmic dosages, is also approved by EU-GMP and ANVISA-Brazil.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..